Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

被引:317
作者
Powles, T. [1 ]
Bellmunt, J. [2 ]
Comperat, E. [3 ]
De Santis, M. [4 ]
Huddart, R. [5 ]
Loriot, Y. [6 ,7 ]
Necchi, A. [8 ]
Valderrama, B. P. [9 ]
Ravaud, A. [10 ,11 ]
Shariat, S. F. [12 ]
Szabados, B. [1 ,13 ]
van der Heijden, M. S. [14 ]
Gillessen, S. [15 ]
机构
[1] Queen Mary Univ London, Barts Canc Ctr, Barts Hlth NHS Trust, London, England
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, IMIM Lab, Boston, MA 02115 USA
[3] Hop Tenon, Assistance Publ Hop Paris, Paris, France
[4] Charite, Dept Urol, Berlin, Germany
[5] Royal Marsden Hosp, Inst Canc Res, London, England
[6] Univ Paris Saclay, Dept Med Oncol, Villejuif, France
[7] Gustave Roussy, Villejuif, France
[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Hosp, Dept Med Oncol, Milan, Italy
[9] Univ Hosp Virgen del Rocio, Seville, Spain
[10] Hop St Andre CHU, Bordeaux, France
[11] Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France
[12] Med Univ Vienna, Vienna Gen Hosp, Dept Urol, Vienna, Austria
[13] Univ Coll London Hosp, Dept Urol, London, England
[14] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[15] EOC, Oncol Inst Southern Switzerland IOSI, Lugano, Switzerland
关键词
immune checkpoint inhibitors; fibroblast growth factor receptor inhibitors; antibody drug conjugates; bladder cancer; urothelial carcinoma; platinum-based chemotherapy; METASTATIC UROTHELIAL CARCINOMA; BACILLUS-CALMETTE-GUERIN; PHASE-III TRIAL; TRANSITIONAL-CELL CARCINOMA; COMBINED-MODALITY TREATMENT; RADICAL CYSTECTOMY; OPEN-LABEL; SINGLE-ARM; ADJUVANT CHEMOTHERAPY; PREDICTING RECURRENCE;
D O I
10.1016/j.annonc.2021.11.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:244 / 258
页数:15
相关论文
共 121 条
[91]   Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the bladder cancer research consortium [J].
Shariat, Shahrokh F. ;
Karakiewicz, Pierre I. ;
Palapattu, Ganesh S. ;
Lotan, Yair ;
Rogers, Craig G. ;
Amiel, Gilad E. ;
Vazina, Amnon ;
Gupta, Amit ;
Bastian, Patrick J. ;
Sagalowsky, Arthur I. ;
Schoenberg, Mark P. ;
Lerner, Seth P. .
JOURNAL OF UROLOGY, 2006, 176 (06) :2414-2422
[92]   Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy [J].
Shariat, Shahrokh F. ;
Rink, Michael ;
Ehdaie, Behfar ;
Xylinas, Evanguelos ;
Babjuk, Marek ;
Merseburger, Axel S. ;
Svatek, Robert S. ;
Cha, Eugene K. ;
Tagawa, Scott T. ;
Fajkovic, Harun ;
Novara, Giacomo ;
Karakiewicz, Pierre I. ;
Quoc-Dien Trinh ;
Daneshmand, Siamak ;
Lotan, Yair ;
Kassouf, Wassim ;
Fritsche, Hans-Martin ;
Chun, Felix K. ;
Sonpavde, Guru ;
Joual, Abdennabi ;
Scherr, Douglas S. ;
Gonen, Mithat .
EUROPEAN UROLOGY, 2013, 63 (02) :371-378
[93]   Clinical Nodal Staging Scores for Bladder Cancer: A Proposal for Preoperative Risk Assessment [J].
Shariat, Shahrokh F. ;
Ehdaie, Behfar ;
Rink, Michael ;
Cha, Eugene K. ;
Svatek, Robert S. ;
Chromecki, Thomas F. ;
Fajkovic, Harun ;
Novara, Giacomo ;
David, Scott G. ;
Daneshmand, Siamak ;
Fradet, Yves ;
Lotan, Yair ;
Sagalowsky, Arthur I. ;
Clozel, Thomas ;
Bastian, Patrick J. ;
Kassouf, Wassim ;
Fritsche, Hans-Martin ;
Burger, Maximilian ;
Izawa, Jonathan I. ;
Tilki, Derya ;
Abdollah, Firas ;
Chun, Felix K. ;
Sonpavde, Guru ;
Karakiewicz, Pierre I. ;
Scherr, Douglas S. ;
Gonen, Mithat .
EUROPEAN UROLOGY, 2012, 61 (02) :237-242
[94]   Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial [J].
Sharma, Padmanee ;
Retz, Margitta ;
Siefker-Radtke, Arlene ;
Baron, Ari ;
Necchi, Andrea ;
Bedke, Jens ;
Plimack, Elizabeth R. ;
Vaena, Daniel ;
Grimm, Marc-Oliver ;
Bracarda, Sergio ;
Arranz, Jose Angel ;
Pal, Sumanta ;
Ohyama, Chikara ;
Saci, Abdel ;
Qu, Xiaotao ;
Lambert, Alexandre ;
Krishnan, Suba ;
Azrilevich, Alex ;
Galsky, Matthew D. .
LANCET ONCOLOGY, 2017, 18 (03) :312-322
[95]   Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates - The Massachusetts General Hospital and Radiation Therapy Oncology Group Experiences [J].
Shipley, WU ;
Zietman, AL ;
Kaufman, DS ;
Coen, JJ ;
Sandler, HM .
SEMINARS IN RADIATION ONCOLOGY, 2005, 15 (01) :36-41
[96]  
Siefker-Radtke AO, 2020, J CLIN ONCOL, V38
[97]  
Siegel Cary, 2005, J Urol, V174, P1250, DOI 10.1097/S0022-5347(01)68587-2
[98]   Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy [J].
Simone, Giuseppe ;
Papalia, Rocco ;
Ferriero, Mariaconsiglia ;
Guaglianone, Salvatore ;
Castelli, Emanuele ;
Collura, Devis ;
Muto, Giovanni ;
Gallucci, Michele .
INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (04) :390-397
[99]   Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma [J].
Sonpavde, Guru ;
Pond, Gregory R. ;
Choueiri, Toni K. ;
Mullane, Stephanie ;
Niegisch, Guenter ;
Albers, Peter ;
Necchi, Andrea ;
Di Lorenzo, Giuseppe ;
Buonerba, Carlo ;
Rozzi, Antonio ;
Matsumoto, Kazumasa ;
Lee, Jae-Lyun ;
Kitamura, Hiroshi ;
Kume, Haruki ;
Bellmunt, Joaquim .
EUROPEAN UROLOGY, 2016, 69 (04) :634-641
[100]   Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma [J].
Sonpavde, Guru P. ;
Mariani, Luigi ;
Lo Vullo, Salvatore ;
Raggi, Daniele ;
Giannatempo, Patrizia ;
Bamias, Aristotle ;
Crabb, Simon J. ;
Bellmunt, Joaquim ;
Yu, Evan Y. ;
Niegisch, Guenter ;
Vaishampayan, Ulka N. ;
Theodore, Christine ;
Berthold, Dominik R. ;
Srinivas, Sandy ;
Sridhar, Srikala S. ;
Plimack, Elizabeth R. ;
Rosenberg, Jonathan E. ;
Powles, Thomas ;
Galsky, Matthew D. ;
Necchi, Andrea .
JOURNAL OF UROLOGY, 2018, 200 (06) :1207-1214